Literature DB >> 1699472

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.

P J Goadsby1, L Edvinsson, R Ekman.   

Abstract

The innervation of the cranial vessels by the trigeminal nerve, the trigeminovascular system, has recently been the subject of study in view of its possible role in the mediation of some aspects of migraine. Since stimulation of the trigeminal ganglion in humans leads to facial pain and flushing and associated release of powerful neuropeptide vasodilator substances, their local release into the extracerebral circulation of humans was determined in patients who had either common or classic migraine. Venous blood was sampled from both the external jugular and cubital fossa ipsilateral to the side of headache. Plasma levels of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide were determined using sensitive radioimmunoassays for each peptide, and values for the cubital fossa and external jugular and a control population were compared. A substantial elevation of the calcitonin gene-related peptide level in the external jugular but not the cubital fossa blood was seen in both classic and common migraine. The increase seen in classic migraine was greater than that seen with common migraine. The other peptides measured were unaltered. This finding may have importance in the pathophysiology of migraine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699472     DOI: 10.1002/ana.410280213

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  348 in total

1.  Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals.

Authors:  A Sams-Nielsen; C Orskov; I Jansen-Olesen
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

2.  BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37).

Authors:  Raphaela Verheggen; Katja Bumann; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

Review 3.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

Review 4.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

Review 5.  Obesity and chronic daily headache.

Authors:  Marcelo E Bigal; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 6.  Ophthalmologic migraine.

Authors:  Robert F Saul
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

Review 7.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

8.  Migraine and subclinical atherosclerosis: endothelial dysfunction biomarkers and carotid intima-media thickness: a case-control study.

Authors:  Aynur Yilmaz Avci; Mehmet Husamettin Akkucuk; Ebru Torun; Serap Arikan; Ufuk Can; Mustafa Agah Tekindal
Journal:  Neurol Sci       Date:  2019-01-15       Impact factor: 3.307

Review 9.  Evidence based medicine on the use of botulinum toxin for headache disorders.

Authors:  W J Schulte-Mattler; E Leinisch
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

10.  Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism.

Authors:  S Akerman; D J Williamson; P J Goadsby
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.